We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Oryzon Genomics S.A.

Oryzon Genomics, S.A. is a European biopharmaceutical company focused on developing diagnostic and therapeutic products in oncology and neurodegeneration. Oryzon’s mission is to use its integrated discovery platform to develop biotechnological products that improve the health of patients. Our diagnostic R&D pipeline has a preventative healthcare focus with projects concentrated on identifying diseases earlier so that they can be treated more effectively. Our therapeutic pipeline is focused on treating fatal diseases in novel ways that attack the underlying causes of the disorders in question.


Oryzon Genomics S.A.

San Ferran 74
08940 Bacelona
Field of Activity:
Clinical Research
Hospital & Medical Practice
Other Activities
Research & Education